Middle East and Africa Breast Implants Market Report and Forecast 2024-2032

The global breast implants market was valued at USD 2.49 billion in 2023, with the Middle East and Africa holding a significant market share. The market is driven by the increasing prevalence of breast cancer and the rising advancements in breast implant technology. It is expected to grow at a CAGR of 8.5% during the forecast period of 2024-2032, with the values likely to attain USD 5.15 billion by 2032.

Middle East and Africa Breast Implants Market Outlook

• Recent data reveals that the incidence of breast cancer is increasing at a sharp rate in Saudi Arabia, with the National Cancer Registry (SCR) stating the age-standardized incidence (ASR) of this cancer in the country has almost tripled over the last few decades. This growing incidence of breast cancer is poised to augment the market demand for breast implants.
• One of the major Middle East and Africa breast implants market trends is the surge in the approval of new and advanced breast implant products by health regulatory agencies. For instance, in December 2022, Sientra, Inc., received marketing approval from the United Arab Emirates Ministry of Health and Prevention for its line of smooth surface, high-strength cohesive silicone gel breast implants in the United Arab Emirates.
• The market share is influenced by the rising disposable incomes in several countries within the region. Further, the increasing investments in healthcare infrastructure and services including cosmetic surgery facilities are contributing to the market expansion.

Middle East and Africa Breast Implants Market Analysis

Breast implants are implanted under the breast tissue or chest muscles to increase the size or change the shape or texture of the breasts. They are primarily used for cosmetic enhancements or reconstructive plastic surgery to restore the breast shape after mastectomy. As the global breast implants market expands, technologically advanced implants such as those with cohesive gel properties or better texturing have entered the Middle East and Africa market. This has raised the standard of care and options available to patients. Moreover, many countries within the region are making substantial investments in healthcare infrastructure and services including cosmetic surgery facilities which are expected to drive the Middle East and Africa breast implants market growth.

The market is influenced by rising cases of breast cancer which is likely to increase the volume of post-mastectomy reconstruction procedures requiring breast implants. Breast cancer is reported to be the most prevalent cancer in women. Recent data reveals that the incidence of breast cancer is rising at a sharp rate in Saudi Arabia, with the National Cancer Registry (SCR) stating the age-standardized incidence (ASR) of this cancer in the country has almost tripled over the last few decades. Thus, this rising incidence of breast cancer is anticipated to support market expansion in the coming years. Additionally, the rising disposable incomes in several countries within this region allow more individuals to afford cosmetic surgeries, including breast augmentation procedures, which is poised to augment the Middle East and Africa breast implants market demand.

One of the major market trends is the surge in the approval of new and advanced breast implant products by health regulatory agencies in the region. For instance, in December 2022, Sientra, Inc., a United States-based medical aesthetics company focused exclusively on plastic surgery, received marketing approval from the United Arab Emirates Ministry of Health and Prevention for its line of smooth surface, High-Strength Cohesive (HSC and HSC+) silicone gel breast implants in the United Arab Emirates. The product was granted accelerated approval based on its exceptional 10-year clinical safety data and will be distributed through Sientra’s local partner Rose Aljazera. The rising introduction of such innovative breast implant technologies in the region is projected to boost the market share.

Middle East and Africa Breast Implants Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

• Silicone Implant
• Form-stable Implant
• Saline Implant
• Structured Saline Implant

Market Breakup by Shape

• Round Implant Shape
• Anatomical Implant Shape

Market Breakup by Surface

• Textured
• Smooth

Market Breakup by Application

• Cosmetic Surgery
• Reconstructive Surgery

Market Breakup by End User

• Cosmetology Clinics
• Ambulatory Surgical Centres
• Cosmetic

Market Breakup by Country

• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Leading Players in the Middle East and Africa Breast Implants Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Genetix Biotech Asia Pvt. Ltd.
• AbbVie Inc.
• Mentor Worldwide LLC
• Sientra Inc.
• Establishment Labs S.A.
• GC Aesthetics
• Polytech Health & Aesthetics GmbH
• Groupe Sebbin SAS
• POLYTECH Health & Aesthetics GmbH
• Silimed

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

FAQs

What is the Middle East and Africa breast implants market forecast outlook for 2024-2032?
The Middle East and Africa breast implants market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 8.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 5.15 billion by 2032.

What are the major factors aiding the Middle East and Africa breast implants market demand?
The increasing prevalence of breast cancer and the rising advancements in breast implant technology are fuelling the demand for the market.

What are the major Middle East and Africa breast implants market trends?
One of the significant trends in the market is the increasing approval of advanced breast implant products by health regulatory agencies. In December 2022, Sientra, Inc., received marketing approval from the United Arab Emirates Ministry of Health and Prevention for its High-Strength Cohesive silicone gel breast implants in the United Arab Emirates.

What is the market segmentation based on the type?
Based on the type, the market is segmented into silicone implants, form-stable implants, saline implants, and structured saline implants.

What is the market breakup by shape?
By shape, the market is divided into round implant shape and anatomical implant shape.

What is the market segmentation based on the surface?
The market breakup by surface includes textured and smooth.

What are the major end users of breast implants?
End users of the market are cosmetology clinics, ambulatory surgical centers, and cosmetics.

What are the applications of breast implants?
Major application areas include cosmetic surgery and reconstructive surgery.

What is the market segmentation by countries?
The market segmentation by countries includes Saudi Arabia, the United Arab Emirates, Nigeria, and South Africa, among others.

Who are the key players involved in the Middle East and Africa breast implants market?
The key players in the market are Genetix Biotech Asia Pvt. Ltd., AbbVie Inc., Mentor Worldwide LLC, Sientra Inc., Establishment Labs S.A., GC Aesthetics, Polytech Health & Aesthetics GmbH, Groupe Sebbin SAS, POLYTECH Health & Aesthetics GmbH, and Silimed.


This product will be delivered within 5-7 business days.